Meet our highly trained physicians
Blue Horizon Stem Cells employs the finest physicians from around the world. Most of our physicians have been trained in the United States and have over 20 years experience in areas such as Neuropsychopharmacology, Biochemistry, Orthopedic Surgery and Cancer Research. They have been the recipients of numerous awards and recognitions for their ground breaking research in stem cell therapies.
Dr. Brian Mehling – Founder and Chief Medical Officer
Dr. Brian Mehling is the founder and Chief Medical Officer of Blue Horizon International, LLC. He is also an orthopedic surgeon, practicing in New York and New Jersey. Dr. Mehling served his residency at St. Joseph’s Hospital, Paterson, New Jersey in Orthopaedic Surgery and trained in sports medicine at Graduate Hospital, Philadelphia, Pennsylvania. He is a graduate of The Ohio State University with a Master’s of Science in Biochemistry. Blue Horizon International LLC was first conceived by Dr. Mehling during a visit abroad in 2006, when he recognized the significant need for high quality health care in foreign regions with American surgeons and medical doctors, who are widely regarded as the best in the world, providing such care. Accordingly, he established the goal to bring medical technologies and best practices in patient care from the United States to global regions. Under his guidance, Blue Horizon International LLC provides an opportunity for the global community to participate in ground-breaking research and receive stem cell therapy with state-of-the-art procedures and safety conditions.. Full CV and list of publications.
Dr. Dongcheng Wu, MD, Ph.D – Director of The Stem Cell Center
Dr. Wu is currently a Professor at Wuhan University School of Basic Medical Science, Chu Tian Scholar, and Director of the Stem Cell Centre, Hongqiao Brain Hospital. Dr. Wu and his team focus on designing clinical trials using human neural stem cells and human bone marrow mesenchymal cells for spinal cord injury. Dr. Wu started his medical career in 1987 as Resident physician of Paediatrics at the People’s Hospital of Hubei Province, Wuhan, China. Dr. Wu continued on as a Ph.D. student of Wuhan University and was sent to McMaster University as an exchange student to finish my Ph.D. thesis. His project was to investigate the mechanisms whereby the cancer cell cycle is arrested during DNA damage, which is relevant to how cancer cells respond to chemotherapy. He continued Post-Doctoral Research at Stem Cell and Cancer Research Centre, McMaster University, Hamilton, Ontario, Canada and is a leading expert in stem cell mechanics. Full CV and list of publications.